Skip to main content
Torrent Pharmaceuticals Ltd. logo

Torrent Pharmaceuticals Ltd. — Investor Relations & Filings

Ticker · TORNTPHARM ISIN · INE685A01028 LEI · 335800NA6HK275RIJE13 BSE.NS Manufacturing
Open in API
Filings indexed 1,764 across all filing types
Latest filing 2023-08-23 Regulatory Filings
Country IN India
Listing BSE.NS TORNTPHARM

About Torrent Pharmaceuticals Ltd.

https://www.torrentpharma.com

Torrent Pharmaceuticals Ltd. is a research-driven organization focused on the development, manufacturing, and marketing of generic formulations. The company holds a significant position in therapeutic areas such as cardiovascular, central nervous system, gastrointestinal, diabetology, and anti-infective treatments. It has strategically expanded its portfolio into dermatology, nephrology, and pain management through targeted acquisitions. The firm operates across multiple international markets, supported by advanced research and development centers and manufacturing facilities that adhere to global regulatory standards. Its core operations prioritize chronic therapy leadership and the provision of high-quality healthcare solutions through a robust pipeline of generic and value-added medicines.

Recent filings

Filing Released Lang Actions
Updates
Regulatory Filings Classification · 95% confidence The document text contains only placeholders for images and no substantive text or financial data. The true document length is only 108 characters, indicating it is extremely short and does not contain any report content. There is no indication of any report, announcement, or filing type. Given the lack of content, this document does not fit any specific report category and defaults to Regulatory Filings (RNS) as a fallback category.
2023-08-23 English
Loss of Share Certificates
Regulatory Filings
2023-08-19 English
Intimation of Loss of Share Certificate
Regulatory Filings
2023-08-19 English
Transcript of Conference call with Analysts / investors on financial results for the quarter ended 30th June, 2023 attached.
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the stock exchange listing department, referencing a transcript of a conference call with analysts and investors regarding the financial results for the quarter ended June 30, 2023. It states that the transcript has been placed on the company's website and provides a link. The document itself does not contain the transcript but announces its availability. The document length is short (1484 characters), and it is primarily an announcement of the transcript's publication, not the transcript itself. According to the rules, such announcements should be classified as Regulatory Filings (RNS) because it is a regulatory announcement about the availability of a call transcript, not the transcript itself.
2023-08-11 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges (BSE and NSE) regarding the loss of share certificates and the issuance of duplicate certificates. It references Regulation 39 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to share certificate loss and related disclosures. The content is about notifying the exchanges and market participants to refrain from trading the lost shares and does not contain financial data, earnings, management discussion, or any report publication. It is a regulatory compliance announcement related to share certificates, not a financial report or meeting material. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2023-08-09 English
Intimation of Loss of Share Certificates
Regulatory Filings Classification · 100% confidence The document is an official communication addressed to stock exchanges (BSE and NSE) regarding the loss of share certificates and the issuance of duplicate certificates. It references Regulation 39 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to share certificate loss and related disclosures. The content includes details of shareholders, folio numbers, certificate numbers, and a request to trading members to refrain from trading these shares. There is no financial data, earnings information, or report publication mentioned. The document is a regulatory announcement about share certificate loss and related procedural information, fitting the category of Regulatory Filings (RNS). The document length is short and does not contain a report or financial statements, so it is not a report publication announcement (RPA).
2023-08-09 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.